A process for the preparation of alpha' chloroketones

Details for Australian Patent Application No. 2001282944 (hide)

Owner Bristol-Myers Squibb Company

Inventors Schwinden, Mark D.; Kronenthal, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001282944

PCT Pub. Number WO02/14256

Priority 60225711 16.08.00 US

Filing date 20 July 2001

Wipo publication date 25 February 2002

Acceptance publication date 4 August 2005

International Classifications

C07C 045/61 Preparation of compounds having CO groups bound only to carbon or hydrogen atoms

C07D 301/24 Heterocyclic compounds having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as ring hetero atoms

C07D 301/00 Heterocyclic compounds having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as ring hetero atoms

Event Publications

4 August 2005 Application Accepted

  Published as AU-B-2001282944

15 December 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001282945-Mu-conopeptides

2001282943